YI-CHEN LAI to Anticonvulsants
This is a "connection" page, showing publications YI-CHEN LAI has written about Anticonvulsants.
Connection Strength
0.891
-
Time to treatment in pediatric patients with repeated episodes of status epilepticus. BMC Neurol. 2025 May 26; 25(1):221.
Score: 0.189
-
Lack of association of first and second-line medication dosing and progression to refractory status epilepticus in children. Seizure. 2024 Dec; 123:133-141.
Score: 0.182
-
First-line medication dosing in pediatric refractory status epilepticus. Neurology. 2020 11 10; 95(19):e2683-e2696.
Score: 0.136
-
Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers. Pediatr Neurol. 2018 09; 86:33-41.
Score: 0.117
-
Factors associated with treatment delays in pediatric refractory convulsive status epilepticus. Neurology. 2018 05 08; 90(19):e1692-e1701.
Score: 0.115
-
Early Clinical Variables Associated With Refractory Convulsive Status Epilepticus in Children. Neurology. 2023 08 01; 101(5):e546-e557.
Score: 0.041
-
Super-Refractory Status Epilepticus in Children: A Retrospective Cohort Study. Pediatr Crit Care Med. 2021 12 01; 22(12):e613-e625.
Score: 0.037
-
Benzodiazepine administration patterns before escalation to second-line medications in pediatric refractory convulsive status epilepticus. Epilepsia. 2021 11; 62(11):2766-2777.
Score: 0.036
-
Factors associated with long-term outcomes in pediatric refractory status epilepticus. Epilepsia. 2021 09; 62(9):2190-2204.
Score: 0.036